These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 29503651)

  • 1. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
    Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
    Front Immunol; 2018; 9():290. PubMed ID: 29503651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.
    Dáňová K; Grohová A; Strnadová P; Funda DP; Šumník Z; Lebl J; Cinek O; Průhová Š; Koloušková S; Obermannová B; Petruželková L; Šedivá A; Fundová P; Buschard K; Špíšek R; Palová-Jelínková L
    J Immunol; 2017 Jan; 198(2):729-740. PubMed ID: 27927966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
    Funda DP; Palová-Jelínková L; Goliáš J; Kroulíková Z; Fajstová A; Hudcovic T; Špíšek R
    Front Immunol; 2019; 10():967. PubMed ID: 31139178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
    Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
    Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
    Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
    J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease.
    Geng L; Solimena M; Flavell RA; Sherwin RS; Hayday AC
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10055-60. PubMed ID: 9707599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice.
    Zekzer D; Wong FS; Ayalon O; Millet I; Altieri M; Shintani S; Solimena M; Sherwin RS
    J Clin Invest; 1998 Jan; 101(1):68-73. PubMed ID: 9421467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
    Chen C; Lee WH; Yun P; Snow P; Liu CP
    J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells.
    Machen J; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
    J Immunol; 2004 Oct; 173(7):4331-41. PubMed ID: 15383562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
    Mukherjee R; Chaturvedi P; Qin HY; Singh B
    J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
    J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
    Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
    Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.
    Gong Z; Pan L; Le Y; Liu Q; Zhou M; Xing W; Zhuo R; Wang S; Guo J
    Vaccine; 2010 May; 28(24):4052-8. PubMed ID: 20406664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.
    Posgai AL; Wasserfall CH; Kwon KC; Daniell H; Schatz DA; Atkinson MA
    Sci Rep; 2017 Feb; 7():42372. PubMed ID: 28205558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543).
    Overbergh L; Decallonne B; Waer M; Rutgeerts O; Valckx D; Casteels KM; Laureys J; Bouillon R; Mathieu C
    Diabetes; 2000 Aug; 49(8):1301-7. PubMed ID: 10923629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
    Tisch R; Wang B; Atkinson MA; Serreze DV; Friedline R
    J Immunol; 2001 Jun; 166(11):6925-36. PubMed ID: 11359854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice.
    Tai N; Yasuda H; Xiang Y; Zhang L; Rodriguez-Pinto D; Yokono K; Sherwin R; Wong FS; Nagata M; Wen L
    Clin Immunol; 2011 Jun; 139(3):336-49. PubMed ID: 21458378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
    Saï P; Rivereau AS; Granier C; Haertlé T; Martignat L
    Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells.
    Krueger T; Wohlrab U; Klucken M; Schott M; Seissler J
    Diabetologia; 2003 Oct; 46(10):1357-65. PubMed ID: 12928772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
    Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.